Literature DB >> 21641711

Usefulness of routine laboratory parameters in the decision to treat refractory cardiac arrest with extracorporeal life support.

Bruno Mégarbane1, Nicolas Deye, Mounir Aout, Isabelle Malissin, Dabor Résière, Hakim Haouache, Pierre Brun, William Haik, Pascal Leprince, Eric Vicaut, Frédéric J Baud.   

Abstract

AIM: To evaluate the usefulness of routine laboratory parameters in the decision to treat refractory cardiac arrest patients with extracorporeal life support (ECLS).
METHODS: Sixty-six adults with witnessed cardiac arrest of cardiac origin unrelated to poisoning or hypothermia undergoing cardiopulmonary resuscitation without return of spontaneous circulation (duration: 155 min [120-180], median, [25-75%-percentiles]) were included in a prospective cohort-study. ECLS was implemented under cardiac massage, using a centrifugal pump connected to a hollow-fiber membrane-oxygenator, aiming to maintain ECLS flow ≥ 2.5 l/min and mean arterial pressure ≥ 60 mm Hg.
RESULTS: Forty-seven of 66 patients died within 24 h from multiorgan failure and massive capillary leak. Of 19/66 patients who survived ≥ 24 h with stable circulatory conditions permitting neurological evaluation, four became conscious and were transferred for further cardiac assistance, while three became organ donors. Ultimately, one patient survived without neurologic sequelae after cardiac transplantation. Using multivariate analysis, only pre-cannulation peripheral venous oxygen saturation (SpvO₂, 28% [15-52]) independently predicted inability to maintain targeted ECLS conditions ≥ 24 h (odds ratio for each 10%-decrease [95%-confidence interval]: 1.65 [1.21; 2.25], p=0.002). The area under the receiver-operating-characteristics curve was 0.78 [0.63; 0.93]. SpvO₂ cut-off value of 33% was associated with a sensitivity of 0.68 [0.50; 0.83] and specificity of 0.81 [0.54; 0.96]. SpvO₂ ≤ 8%, lactate concentration ≥ 21 mmol/l, fibrinogen ≤ 0.8 g/l, and prothrombin index ≤ 11% predicted premature ECLS discontinuation with a specificity of 1.
CONCLUSION: SpvO₂ is useful to predict the inability of maintaining refractory cardiac arrest victims on ECLS without detrimental capillary leak and multiorgan failure until neurological evaluation.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21641711     DOI: 10.1016/j.resuscitation.2011.05.007

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  17 in total

1.  [Use of ECMO in adult patients with cardiogenic shock: a position paper of the Austrian Society of Cardiology].

Authors:  Philipp Pichler; Herwig Antretter; Martin Dünser; Stephan Eschertzhuber; Roman Gottardi; Gottfried Heinz; Gerhard Pölzl; Ingrid Pretsch; Angelika Rajek; Andrä Wasler; Daniel Zimpfer; Alexander Geppert
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-09       Impact factor: 0.840

2.  Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team.

Authors:  Sabina Guenther; Hans D Theiss; Matthias Fischer; Stefan Sattler; Sven Peterss; Frank Born; Maximilian Pichlmaier; Steffen Massberg; Christian Hagl; Nawid Khaladj
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-12-13

3.  [Use of ECMO in adult patients with cardiogenic shock: a position paper of the Austrian Society of Cardiology].

Authors:  Philipp Pichler; Herwig Antretter; Martin Dünser; Stephan Eschertzhuber; Roman Gottardi; Gottfried Heinz; Gerhard Pölzl; Ingrid Pretsch; Angelika Rajek; Andrä Wasler; Daniel Zimpfer; Alexander Geppert
Journal:  Wien Klin Wochenschr       Date:  2015-03-28       Impact factor: 1.704

4.  [Are there any prognostic predictors for extracorporeal cardiopulmonary resuscitation (ECPR) in case of out-of-hospital cardiac arrest?]

Authors:  G Michels; H Thiele; S Kluge; R Pfister
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-06-14       Impact factor: 0.840

Review 5.  Clinical significance of lactate in acute cardiac patients.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Gian Franco Gensini
Journal:  World J Cardiol       Date:  2015-08-26

6.  Extracorporeal life support during cardiac arrest resuscitation in a porcine model of ventricular fibrillation.

Authors:  Joshua C Reynolds; David D Salcido; Matthew L Sundermann; Allison C Koller; James J Menegazzi
Journal:  J Extra Corpor Technol       Date:  2013-03

Review 7.  Venous-arterial extracorporeal membrane oxygenation for refractory cardiac arrest: a clinical challenge.

Authors:  Chiara Lazzeri; Pasquale Bernardo; Andrea Sori; Lisa Innocenti; Pierluigi Stefano; Adriano Peris; Gian F Gensini; Serafina Valente
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06

8.  Prognostic Value of Blood Lactate and Base Deficit in Refractory Cardiac Arrest Cases Undergoing Extracorporeal Life Support.

Authors:  Romain Jouffroy; Pascal Philippe; Anastasia Saade; Pierre Carli; Benoit Vivien
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-04-24

Review 9.  The rate of brain death and organ donation in patients resuscitated from cardiac arrest: a systematic review and meta-analysis.

Authors:  Claudio Sandroni; Sonia D'Arrigo; Clifton W Callaway; Alain Cariou; Irina Dragancea; Fabio Silvio Taccone; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2016-10-03       Impact factor: 17.440

10.  Association between Body Temperature Patterns and Neurological Outcomes after Extracorporeal Cardiopulmonary Resuscitation.

Authors:  Jeong-Am Ryu; Taek Kyu Park; Chi Ryang Chung; Yang Hyun Cho; Kiick Sung; Gee Young Suh; Tae Rim Lee; Min Seob Sim; Jeong Hoon Yang
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.